Bristol Myers Squibb Co (BMY)

07:29 AM

Is Bristol Myers Squibb Company stock a safe investment in uncertain markets2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com

07:29 AM

07:13 AM

Good Life Advisors LLC Decreases Position in Bristol Myers Squibb Company $BMY - MarketBeat

07:13 AM

05:15 AM

Is Bristol Myers Squibb Company (BRM) stock a contrarian opportunityMarket Trend Review & Safe Capital Preservation Plans - newser.com

05:15 AM

04:43 AM

Boston Partners Sells 3,760,655 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

04:43 AM

01:14 AM

Scotiabank Initiates Coverage on Bristol Myers (BMY) with Sector Perform Rating and $45 Target - Finviz

01:14 AM

01:12 AM

Is Bristol Myers Squibb Company Celegne Contingent stock resilient in recession scenarios2025 Price Momentum & Long-Term Safe Return Strategies - newser.com

01:12 AM

Nov 15, 2025

Police & Firemen s Retirement System of New Jersey Increases Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 15, 2025

Nov 15, 2025

Banco Bilbao Vizcaya Argentaria S.A. Purchases 15,599 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Nov 15, 2025

Nov 15, 2025

Bristol Myers Squibb Company $BMY Shares Sold by Arvest Bank Trust Division - MarketBeat

Nov 15, 2025

Nov 15, 2025

Allianz SE Lowers Position in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 15, 2025

Nov 14, 2025

Blood thinner failure thins BMS shares - The Pharma Letter

Nov 14, 2025

Nov 14, 2025

Bristol Myers, J&J halt heart drug trial after interim review - ETPharma.com

Nov 14, 2025

Nov 14, 2025

Tech Rebounds After Selloff, Bitcoin Craters To $97,000: What's Moving Markets Friday? - Benzinga

Nov 14, 2025

Nov 14, 2025

Scotiabank Initiates Coverage on Bristol Myers Squibb (NYSE:BMY) - MarketBeat

Nov 14, 2025

Nov 14, 2025

Bristol Myers, J&J’s new blood thinner fails first big test - BioPharma Dive

Nov 14, 2025

Nov 14, 2025

Bristol Myers, J&J stop blood clotting drug trial after interim review - Reuters

Nov 14, 2025

Nov 14, 2025

Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy - Benzinga

Nov 14, 2025

Nov 14, 2025

Wealth Alliance LLC Cuts Stake in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 14, 2025

Nov 14, 2025

Vestmark Advisory Solutions Inc. Trims Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 14, 2025

Nov 14, 2025

Bristol Myers Squibb shares slide after halting key heart trial - MSN

Nov 14, 2025

Nov 14, 2025

Bristol-Myers Squibb stock falls after discontinuing acute coronary trial By Investing.com - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial - statnews.com

Nov 14, 2025

Nov 14, 2025

Bristol Myers (BMY) Drops Following Phase 3 Trial Halt - GuruFocus

Nov 14, 2025

Nov 14, 2025

Bristol Myers falls after halting heart drug trial - TradingView

Nov 14, 2025

Nov 14, 2025

Bristol Myers Squibb discontinues Librexia ACS trial after review By Investing.com - Investing.com Canada

Nov 14, 2025

Nov 14, 2025

Bristol Myers Squibb Company $BMY Shares Sold by Nwam LLC - MarketBeat

Nov 14, 2025

Nov 14, 2025

Cherokee Insurance Co Takes $1.42 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 14, 2025

Nov 14, 2025

Update on phase 3 Librexia ACS trial - MarketScreener

Nov 14, 2025

Nov 14, 2025

Candriam S.C.A. Sells 92,461 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Nov 14, 2025

Nov 14, 2025

Forsta AP Fonden Has $19.34 Million Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 14, 2025

Nov 13, 2025

Q&A: BioNTech co-founders discuss bispecific efforts, Bristol Myers deal, and the irony of competing with Pfizer - Endpoints News

Nov 13, 2025

Nov 13, 2025

Wealth Quarterback LLC Raises Stake in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 13, 2025

Nov 13, 2025

Bristol Myers Squibb Company $BMY Shares Purchased by KBC Group NV - MarketBeat

Nov 13, 2025

Nov 13, 2025

ProShare Advisors LLC Acquires 37,125 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Nov 13, 2025

Nov 13, 2025

Bristol-Myers Squibb’s Oncology Strategy Gains Momentum - AD HOC NEWS

Nov 13, 2025

Nov 12, 2025

SCRI, BMS Expand Collaboration to Accelerate Patient Enrollment - Contract Pharma

Nov 12, 2025

Nov 12, 2025

Bristol Myers Squibb, Sarah Cannon expand oncology trial partnership - Investing.com

Nov 12, 2025

Nov 12, 2025

Does Bristol-Myers Squibb’s Rebound Signal Opportunity After Recent Biotech Acquisitions? - Yahoo Finance

Nov 12, 2025

Nov 12, 2025

Bristol Myers (NYSE: BMY) and SCRI broaden cancer trial access via Accelero at 200+ sites - Stock Titan

Nov 12, 2025

Nov 12, 2025

Zions Bancorporation National Association UT Trims Stake in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 12, 2025

Nov 12, 2025

Evotec and BMS partnership yields IND approval - BioWorld MedTech

Nov 12, 2025

Nov 12, 2025

Evotec Receives $5 Million Milestone Payment From Bristol Myers Under Protein Degradation Partnership - MarketScreener

Nov 12, 2025

Nov 12, 2025

Bristol Myers Squibb Company $BMY Stake Boosted by denkapparat Operations GmbH - MarketBeat

Nov 12, 2025

Nov 12, 2025

Privacy notice center - Bristol Myers Squibb

Nov 12, 2025

Nov 12, 2025

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership - ACCESS Newswire

Nov 12, 2025

Nov 12, 2025

Published on: 2025-11-12 00:59:26 - newser.com

Nov 12, 2025

Nov 12, 2025

Evotec gets USD 5 mln milestone payment from Bristol Myers Squibb - MarketScreener

Nov 12, 2025

Nov 12, 2025

Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership - TradingView

Nov 12, 2025

Nov 11, 2025

Bernstein Assigns Bristol-Myers Squibb Company (BMY) a Hold Rating - Insider Monkey

Nov 11, 2025

Nov 11, 2025

Jim Cramer on Bristol-Myers: “I’m Backing off on It” - Insider Monkey

Nov 11, 2025

Nov 11, 2025

Bristol Myers Squibb Co. Stock Rises Monday, Still Underperforms Market - 富途牛牛

Nov 11, 2025

Nov 11, 2025

Illinois Municipal Retirement Fund Sells 74,227 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Nov 11, 2025

Nov 11, 2025

Daiwa Securities Adjusts Price Target on Bristol-Myers Squibb to $43 From $42, Maintains Neutral Rating - MarketScreener

Nov 11, 2025

Nov 11, 2025

Bristol Myers Squibb Company $BMY Shares Bought by King Luther Capital Management Corp - MarketBeat

Nov 11, 2025

Nov 11, 2025

Midwest Trust Co Invests $5.67 Million in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 11, 2025

Nov 11, 2025

Bristol-Myers Squibb (BMY): Assessing Valuation After Improved Profits and Upgraded Revenue Guidance - Yahoo Finance

Nov 11, 2025

Nov 11, 2025

Prospera Financial Services Inc Sells 10,360 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Nov 11, 2025

Nov 11, 2025

Campbell & CO Investment Adviser LLC Purchases Shares of 42,998 Bristol Myers Squibb Company $BMY - MarketBeat

Nov 11, 2025

Nov 11, 2025

Bristol Myers Squibb Company $BMY Shares Sold by CENTRAL TRUST Co - MarketBeat

Nov 11, 2025

Nov 10, 2025

BofA Remains Neutral on Bristol-Myers Squibb Company (BMY), Expects Low Single-Digit Growth in the Long Term - Insider Monkey

Nov 10, 2025

Nov 10, 2025

Bristol-Myers Squibb (BMY) Completes Significant Debt Offering - GuruFocus

Nov 10, 2025